Cutempa Medical’s first focus are chronic wounds.
1.5% of the global population or
0 million
patients worldwide
are suffering from chronic wounds.
This creates a significant financial burden
for healthcare systems:
$ 0 billion
only for US, Europe and Australia
(excl. costs for amputations).
The problem
in chronic wounds
Wound exudate forms and contains inflammatory cells that help cleanse the wound of germs.1
Due to disrupted and excessive formation of wound exudate, such as in diabetics, maceration (tissue breakdown) occurs.2
The granulation phase cannot begin due to tissue breakdown, leading to impaired wound healing.3